FGEN
FibroGen Inc
Price:  
0.46 
USD
Volume:  
607,697.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN WACC - Weighted Average Cost of Capital

The WACC of FibroGen Inc (FGEN) is 7.6%.

The Cost of Equity of FibroGen Inc (FGEN) is 11.55%.
The Cost of Debt of FibroGen Inc (FGEN) is 5.50%.

Range Selected
Cost of equity 9.20% - 13.90% 11.55%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.8% - 9.4% 7.6%
WACC

FGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.16 1.61
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.20% 13.90%
Tax rate 0.10% 0.20%
Debt/Equity ratio 1.84 1.84
Cost of debt 4.00% 7.00%
After-tax WACC 5.8% 9.4%
Selected WACC 7.6%